BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31875988)

  • 1. Detection of recurrent, rare, and novel gene fusions in patients with acute leukemia using next-generation sequencing approaches.
    Kim B; Kim E; Lee ST; Cheong JW; Lyu CJ; Min YH; Choi JR
    Hematol Oncol; 2020 Feb; 38(1):82-88. PubMed ID: 31875988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
    Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
    Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
    Liu YF; Wang BY; Zhang WN; Huang JY; Li BS; Zhang M; Jiang L; Li JF; Wang MJ; Dai YJ; Zhang ZG; Wang Q; Kong J; Chen B; Zhu YM; Weng XQ; Shen ZX; Li JM; Wang J; Yan XJ; Li Y; Liang YM; Liu L; Chen XQ; Zhang WG; Yan JS; Hu JD; Shen SH; Chen J; Gu LJ; Pei D; Li Y; Wu G; Zhou X; Ren RB; Cheng C; Yang JJ; Wang KK; Wang SY; Zhang J; Mi JQ; Pui CH; Tang JY; Chen Z; Chen SJ
    EBioMedicine; 2016 Jun; 8():173-183. PubMed ID: 27428428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.
    Pincez T; Landry JR; Roussy M; Jouan L; Bilodeau M; Laramée L; Couture F; Sinnett D; Gendron P; Hébert J; Oligny L; Rouette A; Tran TH; Wilhelm BT; Bittencourt H; Cellot S
    Genes Chromosomes Cancer; 2020 Feb; 59(2):125-130. PubMed ID: 31515871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Application of Targeted RNA Sequencing for KMT2A-Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia.
    Dai B; Yu H; Ma T; Lei Y; Wang J; Zhang Y; Lu J; Yan H; Jiang L; Chen B
    J Mol Diagn; 2021 Nov; 23(11):1478-1490. PubMed ID: 34384895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization.
    Krystel-Whittemore M; Taylor MS; Rivera M; Lennerz JK; Le LP; Dias-Santagata D; Iafrate AJ; Deshpande V; Chebib I; Nielsen GP; Wu CL; Nardi V
    Hum Pathol; 2019 Nov; 93():65-73. PubMed ID: 31430493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relatively favorable prognosis for MLL-rearranged childhood acute leukemia with reciprocal translocations.
    Yang L; Ding L; Liang J; Chen J; Tang Y; Xue H; Gu L; Shen S; Li B; Chen J
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27266. PubMed ID: 29943896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
    Kim B; Lee H; Shin S; Lee ST; Choi JR
    J Mol Diagn; 2019 Jan; 21(1):163-170. PubMed ID: 30347268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.
    Walter W; Shahswar R; Stengel A; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    BMC Cancer; 2021 Aug; 21(1):886. PubMed ID: 34340673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing.
    Yu G; Yin C; Wu F; Jiang L; Zheng Z; Xu D; Zhou J; Jiang X; Liu Q; Meng F
    Oncol Rep; 2019 Dec; 42(6):2333-2344. PubMed ID: 31638252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic KMT2A/MLLT10 fusion detected by next-generation sequencing in a case of pediatric acute megakaryoblastic leukemia.
    Kim Y; Kim B; Seong MW; Lee DS; Hong KT; Kang HJ; Yun J; Chang YH
    Cancer Genet; 2023 Aug; 276-277():36-39. PubMed ID: 37478796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst.
    Guseva NV; Jaber O; Tanas MR; Stence AA; Sompallae R; Schade J; Fillman AN; Miller BJ; Bossler AD; Ma D
    Genes Chromosomes Cancer; 2017 Apr; 56(4):266-277. PubMed ID: 27910166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia.
    Ma ESK; Wan TSK; Au CH; Ho DN; Ma SY; Ng MHL; Chan TL
    Cancer Genet; 2017 Dec; 218-219():15-19. PubMed ID: 29153093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Novel t(12;17)(p12;p13) in Relapsed Refractory Acute Myeloid Leukemia by Anchored Multiplex PCR(AMP)-based Next-Generation Sequencing.
    Badar T; Johnson L; Trifilo K; Wang H; Kudlow BA; Padron E; Pappenhausen PR; Hussaini MO
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):e28-e31. PubMed ID: 28187034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of RNA-Based Next-Generation Sequencing Assays for the Detection of NTRK Gene Fusions.
    Park HJ; Baek I; Cheang G; Solomon JP; Song W
    J Mol Diagn; 2021 Nov; 23(11):1443-1451. PubMed ID: 34756276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics.
    Engvall M; Cahill N; Jonsson BI; Höglund M; Hallböök H; Cavelier L
    BMC Med Genomics; 2020 Jul; 13(1):106. PubMed ID: 32727569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.